D-0489-2024 Class II Terminated
FDA drug recall D-0489-2024 was initiated by RemedyRepack Inc. on May 2, 2024 and is designated Class II. Reason for recall: Presence of Foreign Tablets: Manufacturer received a report from a Pharmacist who reported finding a tablet of baclofen in a bottle of 1000-count tramadol The recall status is terminated (terminated Sep 9, 2024). Affected quantity: 23,970 Tablets.
Recall details
- Product Type
- Drugs
- Report Date
- May 15, 2024
- Initiation Date
- May 2, 2024
- Termination Date
- Sep 9, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 23,970 Tablets
Product description
TraMADol HCl 50 mg Tablet, Packaged as (a) 30-count blister pack, NDC 70518-3824-00; (b) 90-count blister pack, NDC 70518-3824-02; (a) 180-count blister pack, NDC 70518-3824-03; RX ONLY, MFG: Advagen Pharma Limited, Plainsboro. NJ 08536, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 724.465.8762
Reason for recall
Presence of Foreign Tablets: Manufacturer received a report from a Pharmacist who reported finding a tablet of baclofen in a bottle of 1000-count tramadol
Distribution pattern
Nationwide in the USA
Code information
Lots#: (a)J0732085-101023, Exp (b) B2546618-100523, Exp (c) B2546541-100523
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0489-2024
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026